Welcome to our dedicated page for SCIENTIFIC INDUSTRIES SEC filings (Ticker: SCND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scientific Industries, Inc. filings document the company’s life science tool operations, governance matters and material events tied to its continuing DOTS bioprocessing, VIVID pill counter and Torbal businesses. Recent 8-K and amended 8-K filings cover the completed sale of the Genie Division assets, related pro forma financial information, transition and supply arrangements, and a change in the company’s independent registered public accounting firm.
Proxy filings describe annual meeting voting matters and shareholder governance procedures. Periodic-report notices and Form 10-Q-related disclosures address reporting timing, financial-statement preparation and the company’s formal public-company reporting obligations.
Scientific Industries Inc. reported a stock option grant to its Chief Financial Officer, Zachary Rovinsky. He received options for 25,000 shares of common stock at an exercise price of $0.6000 per share. These options vest on a 4-year cliff from the grant date, meaning none vest until the four-year mark, when they vest in full.
After this award, he holds a total of 45,000 stock options directly. This is a compensation-related, non-market transaction rather than an open-market purchase or sale of common shares.
Scientific Industries Inc. director Michael Blechman received grants of stock options covering a total of 44,000 shares of common stock on February 17, 2026. The awards consist of 24,000 and 20,000 option shares, each with an exercise price of 0.6000 and expiration on February 17, 2036.
The options were granted in lieu of cash director fees and vest over one year at 1/12 per month, providing compensation rather than reflecting open-market buying. Following these grants, Blechman directly holds 116,186 stock options linked to the company’s common stock.
SCIENTIFIC INDUSTRIES INC Chairman of the Board and director John A. Moore made an open-market purchase of the company’s common stock. He bought 1,000 shares on February 19, 2026 at a price of $0.65 per share. Following this transaction, Moore directly owns 917,871 common shares of Scientific Industries.
Scientific Industries Inc. director and chairman John A. Moore received stock option awards as compensation. He was granted stock options covering 230,000 shares of common stock and an additional 30,000-share option, each with a conversion price of $0.6000 per share.
The filing shows these awards were granted in lieu of cash compensation and vest over one year at a rate of 1/12 per month. Following these grants, Moore holds stock options covering 916,871 shares, giving him additional long-term equity exposure but reflecting routine, compensation-related awards rather than open-market purchases.
Scientific Industries Inc. director John J. Nicols received stock options as compensation instead of cash fees. On February 17, 2026, he was granted stock options covering a total of 140,000 shares of Common Stock, with an exercise price of $0.60 per share and an expiration date of February 17, 2036.
The options vest over one year at a rate of 1/12 per month. Following these awards, Nicols holds 275,778 stock options in total, reflecting routine equity-based director compensation rather than open‑market trading.
Scientific Industries, Inc. reported a change in its independent auditor following an acquisition within the accounting industry. Effective January 14, 2026, the company’s Audit Committee dismissed Berkowitz Pollack Brant Advisors + CPAs, LLP (BPB) and approved Carr, Riggs & Ingram, LLC (CRI) as the new independent registered public accounting firm, after CRI acquired certain assets related to BPB’s capital markets practice on January 1, 2026.
BPB had been engaged from August 22, 2025 through December 31, 2025 but issued no audit or review reports during that period. The company states there were no disagreements with BPB on accounting principles, financial statement disclosure, or auditing scope or procedures, and no reportable events under Regulation S‑K during the engagement. The company also states it did not consult with CRI on accounting or auditing matters before the appointment. BPB’s confirming letter to the SEC is filed as an exhibit.
Scientific Industries Inc. officer Zachary Rovinsky, the company’s Chief Financial Officer, reported his beneficial ownership of derivative securities tied to the company’s common stock. The filing shows a stock option covering 20,000 shares of common stock with an exercise price of $0.8 per share, first exercisable on 08/22/2026 and expiring on 08/22/2035. According to the vesting terms, one quarter of the shares vest one year after the vesting commencement date, and the remaining shares vest in thirty-six equal monthly installments starting from that first anniversary.
Scientific Industries, Inc. is asking shareholders to vote at its 2024 Annual Meeting, to be held virtually on January 22, 2026. Shareholders of record as of December 16, 2025, when 11,928,599 common shares were outstanding, may participate and vote.
Investors are being asked to elect two Class A directors, re-nominating Helena Santos and Juergen Schumacher to serve until the meeting covering the year ending December 31, 2027. They are also asked to approve an amendment to the 2022 Equity Incentive Plan to raise the total shares of common stock available for issuance to 3,750,000 shares.
The company notes that, as of December 16, 2025, only 62,919 shares remained available for new grants under the plan. It states that increasing the pool represents about 16.7% of outstanding shares, and that after the increase, shares subject to outstanding awards plus those available for future awards, totaling 4,298,752, would represent about 36% of shares outstanding. Shareholders are also being asked to ratify the appointment of Berkowitz Pollack Brant Advisors + CPAs as independent registered public accounting firm for the fiscal year ending December 31, 2025.
Scientific Industries Inc. director and chairman John Moore reported an insider purchase of 6,500 shares of the company’s common stock on 12/17/2025 at a price of $0.5315 per share. This open-market transaction, disclosed on a Form 4, increased his direct holdings to 663,371 shares of Scientific Industries common stock.
SCIENTIFIC INDUSTRIES INC chairman and director John Moore acquired 11,700 shares of common stock on 12/17/2025 at $0.5435 per share. After this purchase, he directly owns 656,871 shares of the company’s stock.